Home › Amyloidosis › Kansas › Kansas City
Amyloidosis clinical trials in Kansas City, KS
3 studies for Amyloidosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RecruitingPhase 3
- Clinical Trial Site, Kansas City
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RecruitingObservational study
- Clinical Trial Site, Kansas City
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingObservational study
- Clinical Trial Site, Kansas City
About Amyloidosis
Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.
More about Amyloidosis on MedlinePlus
Amyloidosis trials in other cities
- Boston, MA11 studies
- New York City, NY10 studies
- Rochester, MN10 studies
- Dallas, TX9 studies
- Philadelphia, PA7 studies
- Houston, TX6 studies
- Durham, NC6 studies
- Baltimore, MD6 studies
- St. Louis, MO6 studies
- Portland, OR6 studies
- Chicago, IL5 studies
- Nashville, TN5 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.